Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$4M
3 rounds on record
Latest round
$500k
Venture round · Sep 2024 · 2 yr ago
Team
11-50
employees, estimated range
Backers
1
E14 Fund
The money's age
Due for its next round
24 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 16, 2024 Raised a round Venture round $500k · SEC Form D Nov 28, 2023 Raised a round Venture round $3.4M · SEC Form D Dec 20, 2021 Raised a round Convertible Note $50k · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2024 $500k — SEC Form D
Venture round Nov 2023 $3.4M — SEC Form D
Convertible Note Dec 2021 $50k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Capra Biosciences, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Elizabeth OnderkoExecutive Officer, DirectorSEC Form D
Andrew MagyarExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

People

Elizabeth Onderko
Executive Officer, Director
Andrew Magyar
Executive Officer, Director
Pae Wu
Director
Danielle Joseph
Director
Douglas Cameron
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Alexandria United States
HQ
10-50 est. staff

Financials

Total raised
$4M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $500k Details
Venture - Series Unknown 2023 $3.4M Details
Convertible Note 2021 $50k Details